Depomed agrees to buy Janssen’s Nucynta US license for $1.05bn
The Nucynta franchise includes Nucynta ER (tapentadol) extended release tablets that are designed to manage pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN), and Nucynta (tapentadol),
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.